Northview Acquisition Corp Rights NVACR

$0.23 +0.06 (35.35%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
P/E (trailing)
—
P/E (forward)
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
2,496,600
Avg volume
153,720
Day's range
$0.16 – $0.25
Shares out
—
Stochastic %K
81%
Beta
—
Analysts
—
Price target
—

Price

Company profile

NorthView Acquisition Corporation does not have significant operations. The company focuses on effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare innovation. The company was incorporated in 2021 and is based in New York, New York. NorthView Acqu...

Show more

NorthView Acquisition Corporation does not have significant operations. The company focuses on effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare innovation. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.

Phone
212 494 9022
Address
207 West 25th Street, 9th Floor, New York, United States

Latest news

No headlines yet.